RSM logo
Phlebology

Home Current issue Browse archive Alerts About the journal Feedback
 
Phlebology 2007;22:299-302
© 2007 Royal Society of Medicine Press

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergan, J
Right arrow Articles by Cheng, V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original articles

Foam sclerotherapy of venous malformations

J Bergan and V Cheng

Vein Institute of La Jolla, La Jolla, San Diego, CA, USA; Department of Surgery, UCSD School of Medicine, San Diego, CA, USA; Vein Institute of La Jolla, La Jolla, San Diego, CA, USA; Department of Surgery, UCSD School of Medicine, San Diego, CA, USA

Venous malformations may occur either as localized or segmental lesions. Radiologic imaging defines the extent of involvement but magnetic resonance imaging is the best modality: it gives a bright hypersignal on T2-weighted spin-echo sequences.

During a 30-month period, 1427 patients were investigated for venous disorders and 1% were found to have venous angiomata (9 women and 5 men). The age range was 15 to 76 years (mean 30.8 ± 18.6 years). Foam was produced by the Tessari technique using 1% or 2% concentration of polidocanol. The duplex Doppler was used for ultrasound guidance to insure intravenous flow of foam and to monitor effects of treatment.

A goal of pain-free healing of ulcers or cosmetic improvement was set for each patient. The mean number of treatments was 3.6 ± 2.8 (range 1–10). Pain-free healing was achieved in patients with non-healing ulcerations and cosmetically, all of the patients were improved. Sclerosant foam is useful in treating low-flow venous malformations.

Key Words: VEINS • MALFORMATIONS • KLIPPEL-TRENAUNAY SYNDROME • SCLEROTHERAPY • POLIDOCANOL


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
P. Gloviczki, A. Duncan, M. Kalra, G. Oderich, J. Ricotta, T. Bower, M. McKusick, H. Bjarnason, and D. Driscoll
Vascular Malformations: An Update
Perspectives in Vascular Surgery and Endovascular Therapy, June 1, 2009; 21(2): 133 - 148.
[Abstract] [PDF]



Fundamentals of Phlebology